Charlie Stiefel, J.D. joined the board of Arcutis in 2017. Previously, Mr. Stiefel was the Chairman and CEO of Stiefel Laboratories, Inc., a company founded by his family, until it was purchased by GlaxoSmithKline in 2009. Under Mr. Stiefel’s leadership, Stiefel Laboratories quadrupled sales via new product introductions, acquisitions and strategic investments in product development and sales and marketing. He also is Chairman of the Board of Brickell Biotech, Inc., and is a Director of Encore Dermatology, Inc. Previously, he served as a Director of Strata Skin Sciences, Inc.. In 2003, the South Florida Dermatology Foundation awarded him the Lifetime Achievement Award and he was named Ernst & Young’s Entrepreneur of the Year in Health Sciences for the State of Florida in 2006. In 2007, the American Academy of Dermatology honored him with its Distinguished Service Award. In 2015, the American Skin Association presented him with a special award for Distinguished Service to Humanity. In 2019, he was elected into the inaugural class of the Dermatology Hall of Fame—the only non-physician so honored. Mr. Stiefel earned his B.S. degree at Yale University and a JD degree from Albany Law School.